3 minute read
Dec. 28, 2022
Squalamine: a Potential Parkinson’s Treatment
ENT-01
oral ⍺-synuclein aggregation inhibitor completed Ph. IIb for PD + constipation natural product Sci. Adv., 16 November 2022 Enterin Inc., Philadelphia, PA
oral ⍺-synuclein aggregation inhibitor completed Ph. IIb for PD + constipation natural product Sci. Adv., 16 November 2022 Enterin Inc., Philadelphia, PA